The Wegovy pill is an oral version licensed for weight loss, taken at 25 mg a day, and approved by the MHRA in June 2026
FDA Telehealth Warning Letters In early March 2026, the FDA reportedly issued warning letters to multiple telehealth companies regarding compounded GLP-1 marketing practices, with concerns including misleading marketing claims, implications of equivalence with FDA-approved drugs, and obscuring product sourcing
However, there are several theories: Nutritional Deficiencies: Some individuals may experience nutrient deficiencies while taking Ozempic, especially if they have poor dietary habits or malabsorption issues
Teratology 32 , 321 (1985)
Its commonly included on formularies for type 2 diabetes and is often assigned a tier that requires either a copay or coinsurance